RCT of the Effectiveness of Big White Wall Compared to Other Online Support
Launched by UNIVERSITY OF NOTTINGHAM · Sep 12, 2016
Trial Information
Current as of May 13, 2025
Unknown status
Keywords
ClinConnect Summary
Introduction
Unipolar depression and anxiety are respectively the second and seventh leading causes of years lived with disability in the world among all health problems according to the World Health Organisation. Self-support methods of management of depression and anxiety through a population approach such as online therapy and peer support is attractive for a number of reasons including: the scale of the problem and the ability of current services to cope; providing choice about the management of their symptoms; creating personal empowerment; developing supportive social networks; recur...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 16+
- • Live in the County of Nottinghamshire, including Nottingham City
- • Scores between10-20 on the Personal Health Questionnaire (PHQ9) and/or 10+ on Genral Anxiety Disorder Scale (GAD7)
- • Access to internet through a pc or smartphone (Windows, iOS, Android)
- • Able and willing to give informed consent
- Exclusion Criteria:
- • Scores 21 or more on the PHQ-9 (severe depression)
- • And /Or Scores 2 or 3 on PHQ-9 item "thoughts that you would be better off dead or of hurting yourself in some way".
- • Participant does not feel that they are sufficiently proficient in the use of the English Language (BWW and Moodzone are only available in English)
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, Nottinghamshire, United Kingdom
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Trial Officials
Richard Morriss, MD
Principal Investigator
CLAHRC-EM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials